CLSA Joins the Rally for Medical Research to Support Biomedical Research Funding

Sept. 15, 2017

Jenny Carey, CLSA’s Vice President, Federal Government Relations and Alliance Development & Adam Lotspoke, CLSA’s Associate Director, Federal Government Relations, join other biomedical research advocates in meeting with Congressman Salud Carbajal (D-Santa Barbara) during the 4th Annual Rally for Medical Research Hill Day.

This September, CLSA participated in the 4th Annual Rally for Medical Research Hill Day. The rally, comprised of over 300 organizational partners, brings together a broad coalition of stakeholders, including medical researchers, scientists, innovators, and patient advocates from all over the country. This year’s rally consisted of over 350 participants from over 40 states meeting with a total of 243 Members of Congress and their staff.  CLSA has been proud to have been a part of the Rally since its inception.

The goal of the Rally for Medical Research is to convey the importance of protecting, supporting, and supplementing funding to the National Institutes of Health (NIH), and to continue efforts to make funding biomedical research a national priority. The current FY 2018 appropriations package includes an additional $2 billion for NIH, bringing the total funding to $36.1 billion. Rally participants asked Congress to ensure this funding is included in the final bill.

CLSA’s DC office led groups of advocates to meet with the offices of Sens. Dianne Feinstein (D-CA) & Kamala Harris (D-CA) and Reps. Salud Carbajal (D-Santa Barbara), Anna Eshoo (D-Silicon Valley), Darrell Issa (R-Vista ), Nancy Pelosi (D-San Francisco ), Scott Peters (D-San Diego) & Jackie Speier (D-Menlo Park). Earlier this year, CLSA was instrumental in securing a total of 35 members of the California delegation (32 Democrats and 3 Republicans) as cosigners of  a bipartisan House letter in support of $36 billion for NIH in the FY18 Labor-HHS Appropriations Bill. We will continue to engage the delegation on the importance of robust, predictable and sustained funding for NIH, and continued investment to spur innovation and save more lives.

Questions? Please contact Jenny Carey, CLSA’s Vice President of Federal Government Relations and Alliance Development (